In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
"In contrast to findings in older postmenopausal women, this study tells women that taking these types of estrogen-based hormone therapies for a relatively short period of time in their early postmenopausal years may not put them at increased risk for cognitive decline over the long term," says co-author Dr. Susan Resnick of NIA. "Further, it is important to note that we did not find any cognitive benefit after long-term follow-up."
Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were not able to have their tumors surgically removed.
The U.S. Food and Drug Administration (FDA) is investigating an increasing frequency of reports of serious and life-threatening blood clots and severe narrowing of blood vessels (arteries and veins) of patients taking the leukemia chemotherapy drug Iclusig (ponatinib).
Drug delivery into muscle using an autoinjector-akin to the EpiPen used to treat serious allergic reactions-can be a fast, effective way to stop prolonged epileptic seizures.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.